Neva Sgr launches two new EUR 500 million funds

For the new funds, Neva Sgr has set 'challenging objectives, supported by the excellent results achieved so far, the progressive extension of its network of international relations, and the growing interest, also in Italy, in venture capital as an investment tool for qualified operators and private clients,' reads a company note.

'Our funds,' says Remmert, 'enable investors to contribute to the creation and development of innovative technology platforms on key sectors of the economy and society. The goal is to generate a high return on capital by actively participating in solving major global problems. The new Neva II funds will further strengthen our commitment, investing a total of EUR 500 million, for instance in the medical field in projects for the treatment of oncological and autoimmune diseases'.

Neva II aims to raise a final fund size of approximately EUR 400 million, to be invested in the world's best highly innovative emerging companies, while Neva II Italy plans to raise EUR 100 million to be reserved for Italian companies. Both funds have a mandate to focus on companies operating in sectors of priority importance for the future of the planet, such as life sciences, transition

energy, digital transformation, next-generation manufacturing and aerospace.

"Today we are launching the second fund. It is a really big challenge in terms of size (500 million against 250 million for the first fund). We have raised the bar of the challenge incredibly high. We had the ambition when we became Sgr to become a major player in venture capital in Italy. With the two current funds we were already a major player in Italy. Now we want to be one at European level, approaching our new challenge without losing but improving our characteristics: seriousness, intensity of work, transparency,' the chairman concludes.